could glp-1 be the next mental health drug GLP-1s Like Ozempic May a New Treatment for Addiction GLP-1 Medications and Mental Health:

The semaglutide segment held a dominant market share in 2023, with projections indicating sustained growth through 2032

All content on Ground Truthsits newsletters, analyses, and podcasts, are free, open-access

[PMID: 975501] PubMed record related to this compound for laboratory literature review

The products are not medicines or drugs and they have not been approved by the fda to prevent, treat, diagnose, mitigate, or cure any disease, ailment or medical condition

The primary risk is wasting money on poorly absorbed formulations that dont reach therapeutic plasma levels

The results, outlined in Table 3 , reveal substantial improvements in laboratory and clinical outcomes